Analytical Data
-
Gene name
WISP1/CCN4
- Application
-
Alternative Names
CCN4; WISP1c; WISP1i; WISP1tc; CCN family member 4; Wnt-1-induced secreted protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
O95388
-
Expression Region
Cys216~Arg347
-
Molecular Weight
18kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
WISP1, also known as CCN4, is a member of the CCN family of secreted proteins, which play pivotal roles in various biological processes, including cell proliferation, differentiation, and extracellular matrix regulation. Research has identified WISP1/CCN4 as a critical factor involved in the regulation of fibrotic diseases, wound healing, and cancer progression. It functions through complex signaling pathways, interacting with various cell surface receptors and modulating intracellular signaling cascades. The dysregulation of WISP1 has been implicated in several pathological conditions, including fibrosis and malignancies, making it a potential therapeutic target. Studies have demonstrated that enhanced expression of WISP1 correlates with tumor growth and metastasis, highlighting its role as a mediator of the tumor microenvironment. Considering its significance in health and disease, the recombinant production of WISP1/CCN4 protein has gained attention for enabling functional studies and potential therapeutic applications. By utilizing recombinant DNA technology, researchers can produce large quantities of this protein to explore its biological functions, investigate its mechanisms of action in various cellular contexts, and assess its potential as a biomarker or therapeutic agent in fibrotic diseases and cancer. The ongoing research into WISP1/CCN4 promises to deepen our understanding of its role in cellular processes and may facilitate the development of novel strategies for the treatment of related diseases.
